Gene · 873
Papers2,488
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,488
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting. | Front Oncol | 2021 | 35127497 | PubTator, text mining | PubMed |
| Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport. | Front Pharmacol | 2021 | 35126121 | PubTator, text mining | PubMed |
| Epstein-Barr Virus-Positive Langerhans Cell Sarcoma: Is There a Link? A Case Report. | Front Oncol | 2021 | 35117987 | PubTator, text mining | PubMed |
| Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin. | Front Pharmacol | 2021 | 35095511 | PubTator, text mining | PubMed |
| Identification of SRXN1 and KRT6A as Key Genes in Smoking-Related Non-Small-Cell Lung Cancer Through Bioinformatics and Functional Analyses. | Front Oncol | 2021 | 35071014 | PubTator, text mining | PubMed |
| Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291. | Pharmaceutics | 2021 | 35056981 | PubTator, text mining | PubMed |
| Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells. | Molecules | 2021 | 35011295 | PubTator, text mining | PubMed |
| Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles? | Mol Biomed | 2021 | 35006447 | PubTator, text mining | PubMed |
| Chronic IL-1 Exposed AR+ PCa Cell Lines Show Conserved Loss of IL-1 Sensitivity and Evolve Both Conserved and Unique Differential Gene Expression Profiles. | J Cell Signal | 2021 | 34988553 | PubTator, text mining | PubMed |
Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset. | Front Mol Biosci | 2021 | 34970597 | PubTator, text mining | PubMed |
| How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? | Front Med (Lausanne) | 2021 | 34966759 | PubTator, text mining | PubMed |
| An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood-Brain Barrier in Epileptic Patients. | Pharmaceutics | 2021 | 34959403 | PubTator, text mining | PubMed |
| Proteomics Analysis of Tears and Saliva From Sjogren's Syndrome Patients. | Front Pharmacol | 2021 | 34950038 | PubTator, text mining | PubMed |
| Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. | Int J Mol Sci | 2021 | 34948113 | PubTator, text mining | PubMed |
| Expression and Impact of C1GalT1 in Cancer Development and Progression. | Cancers (Basel) | 2021 | 34944925 | PubTator, text mining | PubMed |
| Study of Baicalin toward COVID-19 Treatment: In silico Target Analysis and in vitro Inhibitory Effects on SARS-CoV-2 Proteases. | Biomed Hub | 2021 | 34934765 | PubTator, text mining | PubMed |
| Plant-growth-promoting Caulobacter strains isolated from distinct plant hosts share conserved genetic factors involved in beneficial plant-bacteria interactions. | Arch Microbiol | 2021 | 34932160 | PubTator, text mining | PubMed |
| The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions. | Curr Res Pharmacol Drug Discov | 2021 | 34909662 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. | World J Hepatol | 2021 | 34904030 | PubTator, text mining | PubMed |
| Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol. | Sci Rep | 2021 | 34887513 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/873/papers?page=26